2-chloro-n(6)cyclopentyladenosine and gemcitabine

2-chloro-n(6)cyclopentyladenosine has been researched along with gemcitabine in 1 studies

Compound Research Comparison

Studies (2-chloro-n(6)cyclopentyladenosine)	Trials (2-chloro-n(6)cyclopentyladenosine)	Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine)	Studies (gemcitabine)	Trials (gemcitabine)	Recent Studies (post-2010) (gemcitabine)
252	0	43	12,523	3,208	6,923

Protein Interaction Comparison

Protein	Taxonomy	2-chloro-n(6)cyclopentyladenosine (IC50)	gemcitabine (IC50)
Chain A, DEOXYNUCLEOSIDE KINASE	Drosophila melanogaster (fruit fly)		0.76
Equilibrative nucleoside transporter 1	Homo sapiens (human)		0.19

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cappellacci, L; Franchetti, P; Graser, G; Grifantini, M; Jayaram, HN; Lavecchia, A; Petrelli, R; Saiko, P; Szekeres, T; Vita, P	1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and gemcitabine

Article	Year
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives. Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14 Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Ribonucleotide Reductases; Ribose; Structure-Activity Relationship	2008

Article

Year

Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.

Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Ribonucleotide Reductases; Ribose; Structure-Activity Relationship

2008